BMP Pharma Trading AG (STU:BMP) ROCE % : 45.78% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is BMP Pharma Trading AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BMP Pharma Trading AG's annualized ROCE % for the quarter that ended in Jun. 2024 was 45.78%.

BMP Pharma Trading AG ROCE % Historical Data

The historical data trend for BMP Pharma Trading AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BMP Pharma Trading AG ROCE % Chart

BMP Pharma Trading AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.76

4.84

41.41

21.22

34.79

BMP Pharma Trading AG Semi-Annual Data
	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															41.57	5.12	39.92	29.69	45.78

BMP Pharma Trading AG ROCE % Calculation

BMP Pharma Trading AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4.101	/	( ( (12.289 - 0.54)	+	(12.12 - 0.293) )	/ 2 )
	=	4.101	/	( (11.749	+	11.827)	/ 2 )
	=	4.101	/	11.788
	=	34.79 %

BMP Pharma Trading AG's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	5.414	/	( ( (12.12 - 0.293)	+	(0 - 0) )	/ 1 )
	=	5.414	/	( ( 11.827	+	0 )	/ 1 )
	=	5.414	/	11.827
	=	45.78 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

BMP Pharma Trading AG (STU:BMP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BMP Pharma Trading AG ROCE % Related Terms

Thank you for viewing the detailed overview of BMP Pharma Trading AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BMP Pharma Trading AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » BMP Pharma Trading AG (STU:BMP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bornbarch 16, Norderstedt, SH, DEU, 22848

Website

https://www.bmp.ag

BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.

BMP Pharma Trading AG Headlines

No Headlines